TM201_HUMAN - dbPTM
TM201_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID TM201_HUMAN
UniProt AC Q5SNT2
Protein Name Transmembrane protein 201
Gene Name TMEM201
Organism Homo sapiens (Human).
Sequence Length 666
Subcellular Localization Isoform 2: Nucleus inner membrane
Multi-pass membrane protein . Cytoplasm, cytoskeleton, spindle pole . The C-terminal of isoform 2 is located on the nucleoplasmic side. During interphase, isoform 2 is distributed in the inner nuclear membrane in d
Protein Description Involved in nuclear movement during fibroblast polarization and migration. Proposed to be involved in actin-dependent nuclear movement via association with transmembrane actin-associated nuclear (TAN) lines which are bound to F-actin cables and couple the nucleus to retrograde actin flow (By similarity). Overexpression can recruit Ran GTPase to the nuclear periphery. [PubMed: 27541860; Isoform 2: May define a distinct membrane domain in the vicinity of the mitotic spindle]
Protein Sequence MEGVSALLARCPTAGLAGGLGVTACAAAGVLLYRIARRMKPTHTMVNCWFCNQDTLVPYGNRNCWDCPHCEQYNGFQENGDYNKPIPAQYLEHLNHVVSSAPSLRDPSQPQQWVSSQVLLCKRCNHHQTTKIKQLAAFAPREEGRYDEEVEVYRHHLEQMYKLCRPCQAAVEYYIKHQNRQLRALLLSHQFKRREADQTHAQNFSSAVKSPVQVILLRALAFLACAFLLTTALYGASGHFAPGTTVPLALPPGGNGSATPDNGTTPGAEGWRQLLGLLPEHMAEKLCEAWAFGQSHQTGVVALGLLTCLLAMLLAGRIRLRRIDAFCTCLWALLLGLHLAEQHLQAASPSWLDTLKFSTTSLCCLVGFTAAVATRKATGPRRFRPRRFFPGDSAGLFPTSPSLAIPHPSVGGSPASLFIPSPPSFLPLANQQLFRSPRRTSPSSLPGRLSRALSLGTIPSLTRADSGYLFSGSRPPSQVSRSGEFPVSDYFSLLSGSCPSSPLPSPAPSVAGSVASSSGSLRHRRPLISPARLNLKGQKLLLFPSPPGEAPTTPSSSDEHSPHNGSLFTMEPPHVPRKPPLQDVKHALDLRSKLERGSACSNRSIKKEDDSSQSSTCVVDTTTRGCSEEAATWRGRFGPSLVRGLLAVSLAANALFTSVFLYQSLR
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MEGVSALL
-------CCCHHHHH
10.2422814378
5Phosphorylation---MEGVSALLARCP
---CCCHHHHHHHCC
24.8520068231
40UbiquitinationYRIARRMKPTHTMVN
HHHHHHCCCCEEEEE
44.98-
82PhosphorylationGFQENGDYNKPIPAQ
CCCCCCCCCCCCCHH
26.8722817900
93UbiquitinationIPAQYLEHLNHVVSS
CCHHHHHHHHCHHHC
29.3622817900
95UbiquitinationAQYLEHLNHVVSSAP
HHHHHHHHCHHHCCC
28.0221890473
131UbiquitinationCNHHQTTKIKQLAAF
CCCCCCHHHHHHHHH
51.8222817900
133 (in isoform 2)Ubiquitination-40.5921890473
133 (in isoform 1)Ubiquitination-40.5921890473
133UbiquitinationHHQTTKIKQLAAFAP
CCCCHHHHHHHHHCC
40.5927667366
146PhosphorylationAPREEGRYDEEVEVY
CCCCCCCCCHHHHHH
38.2719060867
153PhosphorylationYDEEVEVYRHHLEQM
CCHHHHHHHHHHHHH
7.2519060867
154UbiquitinationDEEVEVYRHHLEQMY
CHHHHHHHHHHHHHH
18.8721890473
161PhosphorylationRHHLEQMYKLCRPCQ
HHHHHHHHHHHHHHH
10.6617693683
173PhosphorylationPCQAAVEYYIKHQNR
HHHHHHHHHHHHHHH
12.1428152594
174PhosphorylationCQAAVEYYIKHQNRQ
HHHHHHHHHHHHHHH
7.0328152594
188PhosphorylationQLRALLLSHQFKRRE
HHHHHHHHHHHHHHH
18.4021712546
192 (in isoform 2)Ubiquitination-43.9321890473
192UbiquitinationLLLSHQFKRREADQT
HHHHHHHHHHHHHHH
43.9322817900
192 (in isoform 1)Ubiquitination-43.9321890473
1922-HydroxyisobutyrylationLLLSHQFKRREADQT
HHHHHHHHHHHHHHH
43.93-
416PhosphorylationSVGGSPASLFIPSPP
CCCCCCHHHCCCCCC
27.48-
440PhosphorylationLFRSPRRTSPSSLPG
HHCCCCCCCCCCCCC
46.3930266825
441PhosphorylationFRSPRRTSPSSLPGR
HCCCCCCCCCCCCCH
22.4529255136
443PhosphorylationSPRRTSPSSLPGRLS
CCCCCCCCCCCCHHH
44.2530266825
444PhosphorylationPRRTSPSSLPGRLSR
CCCCCCCCCCCHHHH
41.8030266825
450PhosphorylationSSLPGRLSRALSLGT
CCCCCHHHHHHHHCC
17.7226055452
454PhosphorylationGRLSRALSLGTIPSL
CHHHHHHHHCCCCCC
24.6229255136
457PhosphorylationSRALSLGTIPSLTRA
HHHHHHCCCCCCCCC
34.7030266825
460PhosphorylationLSLGTIPSLTRADSG
HHHCCCCCCCCCCCC
38.2223927012
462PhosphorylationLGTIPSLTRADSGYL
HCCCCCCCCCCCCCC
28.3123927012
466PhosphorylationPSLTRADSGYLFSGS
CCCCCCCCCCCCCCC
28.4923401153
468PhosphorylationLTRADSGYLFSGSRP
CCCCCCCCCCCCCCC
14.4430108239
471PhosphorylationADSGYLFSGSRPPSQ
CCCCCCCCCCCCHHH
33.0121955146
473PhosphorylationSGYLFSGSRPPSQVS
CCCCCCCCCCHHHCC
40.1821955146
477PhosphorylationFSGSRPPSQVSRSGE
CCCCCCHHHCCCCCC
45.9921955146
480PhosphorylationSRPPSQVSRSGEFPV
CCCHHHCCCCCCCCH
17.0621955146
482PhosphorylationPPSQVSRSGEFPVSD
CHHHCCCCCCCCHHH
34.8624144214
488PhosphorylationRSGEFPVSDYFSLLS
CCCCCCHHHHHHHHH
27.1624144214
490PhosphorylationGEFPVSDYFSLLSGS
CCCCHHHHHHHHHCC
6.3830576142
492PhosphorylationFPVSDYFSLLSGSCP
CCHHHHHHHHHCCCC
23.3624144214
495PhosphorylationSDYFSLLSGSCPSSP
HHHHHHHHCCCCCCC
33.6724144214
497PhosphorylationYFSLLSGSCPSSPLP
HHHHHHCCCCCCCCC
21.3424144214
500PhosphorylationLLSGSCPSSPLPSPA
HHHCCCCCCCCCCCC
49.2524144214
501PhosphorylationLSGSCPSSPLPSPAP
HHCCCCCCCCCCCCC
18.6524144214
505PhosphorylationCPSSPLPSPAPSVAG
CCCCCCCCCCCCCCH
41.1824144214
509PhosphorylationPLPSPAPSVAGSVAS
CCCCCCCCCCHHHHC
27.0624144214
513PhosphorylationPAPSVAGSVASSSGS
CCCCCCHHHHCCCCC
12.5524144214
516PhosphorylationSVAGSVASSSGSLRH
CCCHHHHCCCCCCCC
23.9224144214
517PhosphorylationVAGSVASSSGSLRHR
CCHHHHCCCCCCCCC
29.0530576142
518PhosphorylationAGSVASSSGSLRHRR
CHHHHCCCCCCCCCC
29.8824144214
520PhosphorylationSVASSSGSLRHRRPL
HHHCCCCCCCCCCCC
24.9530576142
529PhosphorylationRHRRPLISPARLNLK
CCCCCCCCCEEECCC
21.8628176443
540UbiquitinationLNLKGQKLLLFPSPP
ECCCCCEEEECCCCC
3.7427667366
545PhosphorylationQKLLLFPSPPGEAPT
CEEEECCCCCCCCCC
36.0726074081
552PhosphorylationSPPGEAPTTPSSSDE
CCCCCCCCCCCCCCC
59.3923401153
553PhosphorylationPPGEAPTTPSSSDEH
CCCCCCCCCCCCCCC
21.8026074081
554UbiquitinationPGEAPTTPSSSDEHS
CCCCCCCCCCCCCCC
34.3927667366
555PhosphorylationGEAPTTPSSSDEHSP
CCCCCCCCCCCCCCC
40.1429116813
556PhosphorylationEAPTTPSSSDEHSPH
CCCCCCCCCCCCCCC
42.9129116813
557PhosphorylationAPTTPSSSDEHSPHN
CCCCCCCCCCCCCCC
51.8929116813
561PhosphorylationPSSSDEHSPHNGSLF
CCCCCCCCCCCCCCC
26.3027174698
566PhosphorylationEHSPHNGSLFTMEPP
CCCCCCCCCCCCCCC
26.1527174698
569PhosphorylationPHNGSLFTMEPPHVP
CCCCCCCCCCCCCCC
26.3927174698
578UbiquitinationEPPHVPRKPPLQDVK
CCCCCCCCCCHHHHH
44.9427667366
585UbiquitinationKPPLQDVKHALDLRS
CCCHHHHHHHHHHHH
31.3029967540
604PhosphorylationGSACSNRSIKKEDDS
CCCCCCCCCCCCCCC
42.9025072903
611PhosphorylationSIKKEDDSSQSSTCV
CCCCCCCCCCCCEEE
42.4723663014
612PhosphorylationIKKEDDSSQSSTCVV
CCCCCCCCCCCEEEE
40.8723663014
614PhosphorylationKEDDSSQSSTCVVDT
CCCCCCCCCEEEEEC
29.5723663014
615PhosphorylationEDDSSQSSTCVVDTT
CCCCCCCCEEEEECC
20.4223663014
616PhosphorylationDDSSQSSTCVVDTTT
CCCCCCCEEEEECCC
17.9923663014
621PhosphorylationSSTCVVDTTTRGCSE
CCEEEEECCCCCCCH
20.6120639409
622PhosphorylationSTCVVDTTTRGCSEE
CEEEEECCCCCCCHH
15.2720639409
623PhosphorylationTCVVDTTTRGCSEEA
EEEEECCCCCCCHHH
27.4420639409
627PhosphorylationDTTTRGCSEEAATWR
ECCCCCCCHHHHHHC
41.10-
649PhosphorylationVRGLLAVSLAANALF
HHHHHHHHHHHHHHH
13.4920860994
657PhosphorylationLAANALFTSVFLYQS
HHHHHHHHHHHHHHH
25.4920860994
658PhosphorylationAANALFTSVFLYQSL
HHHHHHHHHHHHHHH
11.9720860994

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of TM201_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of TM201_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of TM201_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of TM201_HUMAN !!

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of TM201_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-454, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-441; SER-454 ANDSER-529, AND MASS SPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-441 AND SER-454, ANDMASS SPECTROMETRY.
"Quantitative phosphoproteome profiling of Wnt3a-mediated signalingnetwork: indicating the involvement of ribonucleoside-diphosphatereductase M2 subunit phosphorylation at residue serine 20 in canonicalWnt signal transduction.";
Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S.,Li S.-J., Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R.;
Mol. Cell. Proteomics 6:1952-1967(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-146; TYR-153 ANDTYR-161, AND MASS SPECTROMETRY.

TOP